In MM, the cytotoxic effects of bendamustine, melphalan, and doxorubicin on p53-deficient cells are enhanced by AZD7762, a CHK1/CHK2 inhibitor (47). The gene discussed is CHEK1; the disease is Miyoshi myopathy.